Alcudacigib

N/A

Report date: 2026/04/09 20:00:21
NME

Base Information

Drug NameAlcudacigib
Drug Alias NameASP-1570
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiacylglycerol kinase zeta inhibitors
TargetsDiacylglycerol kinase zeta
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto RicoFrance +[6
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesAstellas Pharma Inc
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A